ÂÜÀòÂÒÂ×

Ellen Santangelo has a diverse work experience in the field of chemistry and medicinal research. Ellen is currently working at Oncopeptides AB (publ) as the Chemistry Director since January 2023. Prior to this, they held the position of Principal Scientist at the same company starting in June 2022. Before joining Oncopeptides AB, Ellen worked as a Medicinal Chemist at the company from September 2020.

In 2016, Ellen worked as a Research Scientist at Sprint Bioscience until August 2020. Additionally, they were a Research Scientist at Medivir AB from January to October 2016. Prior to this, they held various roles at Medivir AB, including Research Scientist from August 2014 to September 2015, and Research Scientist/Consultant from Proffice Life Science from March to July 2014.

Ellen started their career at AstraZeneca R&D in August 2007, where they worked as a Senior Research Scientist/Consultant from August 2007 to March 2012.

Overall, Ellen Santangelo has accumulated extensive experience and expertise in chemistry and medicinal research throughout their career.

Ellen Santangelo completed their education at KTH Royal Institute of Technology from 1999 to 2004, where they obtained a PhD in Organic Chemistry. There is no additional information provided about their education history beyond this.